Limited benefit of treatment of diabetic
โ
J. Fagius; A. Brattberg; S. Jameson; C. Berne
๐
Article
๐
1985
๐
Springer
๐
English
โ 763 KB
The effects of the aldose reductase inhibitor, sorbinil, on symptomatic symmetrical diabetic polyneuropathy were studied during a 6-month period in a double-blind parallel group placebo-controlled trial. Twenty-seven patients received sorbinil and 28 placebo. The patients were assessed by clinical e